BioLife Solutions Inc (BLFS)

Operating profit margin

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Operating income US$ in thousands -70,825 -145,541 -35,160 -6,241 -220
Revenue US$ in thousands 142,625 160,996 118,837 48,087 27,366
Operating profit margin -49.66% -90.40% -29.59% -12.98% -0.80%

December 31, 2023 calculation

Operating profit margin = Operating income ÷ Revenue
= $-70,825K ÷ $142,625K
= -49.66%

BioLife Solutions Inc's operating profit margin has experienced fluctuations over the past five years. The company's operating profit margin was exceptionally low in 2022 and 2023, showing signs of significant losses relative to its revenue. However, there was a notable improvement in operating profit margin in 2021 compared to the previous years, though still in the negative territory. The company faced challenges in 2020 with a negative operating profit margin, but this margin was less impacted than in the following years. In 2019, BioLife Solutions Inc had a slightly negative operating profit margin, signaling some operational inefficiencies but to a much lesser extent compared to the more recent years. Overall, the consistent negative operating profit margins indicate that the company has struggled to generate profits from its core operations in recent years, highlighting potential inefficiencies or cost management issues that may need to be addressed.


Peer comparison

Dec 31, 2023

Company name
Symbol
Operating profit margin
BioLife Solutions Inc
BLFS
-49.66%
CONMED Corporation
CNMD
9.69%
LivaNova PLC
LIVN
-6.26%
Masimo Corporation
MASI
6.65%
Medtronic PLC
MDT
15.61%